Aurore Sors

Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis

Aurore Sors, Francette Jean‐Louis, C Pellet et al. · Blood · 2005 · 171 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

Hugues Chabriat, Claudio L. Bassetti, Ute C. Marx et al. · The Lancet Neurology · 2020 · 51 citations · Full text

Medicine, Neurology, Pharmacology +16

Inhibition of IκB Kinase Subunit 2 in Cutaneous T-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents

Aurore Sors, Francette Jean‐Louis, Elodie Bégué et al. · Clinical Cancer Research · 2008 · 50 citations

Medicine, Cancer Biology, Oncology +15

Arsenic Trioxide Induces Apoptosis of Cutaneous T Cell Lymphoma Cells: Evidence for a Partially Caspase-Independent Pathway and Potentiation by Ascorbic Acid (Vitamin C)

Laurence Michel, A. Dupuy, Francette Jean‐Louis et al. · Journal of Investigative Dermatology · 2003 · 48 citations · Full text

Life Sciences, Oncology, Toxicology +16

Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists

Darren Riddy, Anna E. Cook, David M. Shackleford et al. · Neuropharmacology · 2018 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15